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Abstract
The purpose of this project was to evaluate the effectiveness of an educational lifestyle
modification (LM) intervention on blood pressure (BP) among adults with prehypertension.
Prehypertension is a precursor to hypertension (HTN) and is a public epidemic in the United
States. Approximately 68 million (31%) U.S. adult’s aged ≥18 years have hypertension.
Hypertension can cause significant target organ damage, lead to coronary heart disease, heart
failure, stroke, and kidney failure. Early identification and the primary treatment of persons with
prehypertension with LM have the potential to minimize the progression and delay the onset of
comorbidities associated with hypertension. This quality improvement project retrospectively
reviewed changes in blood pressure for a small sample (n=5) of patients diagnosed with
prehypertension who received education about modifying lifestyle behaviors according to
nationally accepted clinical practice guidelines. Blood pressure measurements were extracted
from the medical record beginning at the time of the education through a three month period.
Descriptive data indicates that all five patients had a decrease in systolic and diastolic blood
pressure. The median systolic blood pressure at baseline was 129 mmHg decreasing to 121
mmHg at end of study period. The median diastolic blood pressure was 86 mmHg decreasing to
76 mmHg. Integration of lifestyle modification education and subsequent blood pressure
monitoring during a routine primary care visit is feasible and may help motivate patients to
implement changes and subsequently reduce blood pressure. Future studies should include
identifying strategies for improving patient participation.

Chapter One: Introduction
Prehypertension (preHTN), if untreated, can progress to hypertension (HTN), which is a
significant risk factor for cardiovascular disease (CVD). Lifestyle modification (LM) such as
changes in diet, physical activity, and weight loss is the recommended treatment to lower blood
pressure (BP). Chapter one will discuss the clinical problem of HTN and preHTN, present an
abbreviated literature review of the affect of lifestyle modification on blood pressure, and
describe the clinical practice guidelines for primary care treatment. The purpose of this quality
improvement project, the study questions, and definition of terms are also discussed.
Hypertension & PreHypertension
Hypertension, a precursor to cardiovascular disease, is defined as the force of blood
pushing against the walls of the arteries as the heart pumps blood. HTN can cause significant
target organ damage. It can lead to coronary heart disease, heart failure, stroke, kidney failure,
and other health problems. The prevalence of HTN tends to be higher in the fifth and sixth
decade of life in men and higher in Non-Hispanic blacks or African American populations
(Buttaro, Trybulski, Bailey, & Sandberg-Cook, 2008). In the U.S., HTN is responsible for one
out of every seven deaths annually, has no signs or symptoms, and is known as the silent killer
(NHLBI, 2012). HTN contributes to nearly half of all cardiovascular disease-related deaths in the
United States (MMWR, 2011). Approximately 68 million (31%) U.S. adult’s aged ≥18 years
have HTN. Of these, 48 million (70%) were receiving pharmacologic treatment and 31 million
(46%) had their condition controlled. Control prevalence is low among young adults (31%) and
Mexican Americans (37%). Prevention and treatment guidelines are available to guide both
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providers and their patients but patients sometimes fail to adhere to provider recommended
lifestyle modifications. As a result, risk factors for CVD, kidney disease, and hypertension are
increased (Svetky et al., 2009).
Slightly elevated blood pressure is known as preHTN representing a systolic blood
pressure of 120-139 mmHg and/or diastolic blood pressure of 80-89 mmHg (USDHHS, 2004). A
population-based survey reported that approximately one-third the US adult population has
preHTN, a risk factor for HTN and eventual CVD (Gadddam, Ventura, & Lavie 2012). The
National Health and Nutrition Examination Survey (NHANES) 1999-2000 data showed that
64% of individuals with preHTN had at least one other cardiovascular risk factor and the
percentage increased to 94% in those aged 60 years or older (Zhang & Li, 2011). A 10-year
cumulative incidence of CVD in persons between 35 and 64 years of age who had high normal
BP was 4% women and 8% men; in older adults 65-90 the incidence was 18% women and 25%
for men. Persons with preHTN can benefit with reduction in BP, blood glucose, lipid levels,
weight loss, stress, healthy diet, increased physical activity, and smoking cessation. These risk
factors for CVD also affect overall health status, health care use, and costs of health care.
The economic burden of HTN was estimated at $76.7 billion in 2010 (Brill, 2011). A
randomized study by Milani and Lavie (2009), and a cross-sectional study conducted by
Mendez-Hernandez et al. (2012), both concluded that wellness intervention and physical activity
had a considerable effect on lowering health care costs. In any case, preventing the progression
of preHTN to HTN is an important individual patient and health care system goal.
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Clinical Practice Guideline JNC7
The Seventh Report of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure, commonly referred to as the JNC7, is the
evidenced-based clinical practice guideline for the prevention and management of HTN
(USDHHS, 2004). Originally published in 1976, the JNC7 guideline has been revised seven
times with the eighth revision in development. The new classification for preHTN is contained in
the JNC7 along with recommendations for treatment through lifestyle modification and
pharmacotherapeutics.
Prehypertension Classification
The increased risk that HTN poses related to cardiovascular disease is the reason for the
revised blood pressure classifications. HTN is classified as a systolic blood pressure (SBP) ≥ 140
mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg. PreHTN is classified as a SBP 120-139
mmHg and/or DBP 80-89 mmHg. Furthermore, the measures classifying HTN among persons
with diabetes have been lowered to <130/80 mmHg. Table 1 compares the blood pressure
classifications between the JNC6 and the JNC7.
Table 1
Comparison of Blood Pressure Classifications, JNC-6 & JNC-7
JNC- 6 Classification
Optimal
Normal
Borderline
Hypertension
Stage 1
Stage 2
Stage 3
Source: (USDHHS, 2004, p. 11)

Blood Pressure Measures
Systolic/diastolic
<120/80
120-129 / 80-84
130-139 / 85-89
≥140/90
140-159 / 90-99
160-179 / 100-109
≥180 / 110

JNC 7 Classification
Normal
Prehypertension
Prehypertension
Hypertension
Stage 1
Stage 2
Stage 2
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PreHTN is not designated as a disease category or a diagnosis; rather it is designed to
identify those individuals at risk of developing HTN. The United States Department of Health
and Human Services (USDHHS, 2004) based changes on new data on the lifetime risk of HTN
and the increased risk of cardiovascular complications associated with BP levels that were
previously considered normal. Reducing blood pressure through lifestyle modifications reduces
the rate of progression to HTN with age and may prevent HTN altogether. Therefore patients
should make lifestyle adjustments; and providers need to be more vigilant in monitoring,
counseling, and adjusting their management of blood pressure, recognizing preHTN.
Lifestyle Modification Treatment
Lifestyle modifications (LM’s) treatment regimen is presented in Table 2. LM’s consist
of weight reduction, Dietary Approach to Stop Hypertension (DASH) diet, dietary sodium
reduction, increase in physical activity, moderation of alcohol consumption, and cessation of
tobacco use. These strategies have been found to reduce systolic blood pressure.
Weight reduction relies on a combination of physical activity and dietary modifications.
Replacing sweets with fruits and vegetables can reduce calories thus helping to reach weight loss
goals. The DASH diet is rich in fruits, vegetables, whole-grain, high fiber foods, fat-free, and
low-fat dairy products, beans, nuts, skinless poultry and lean meats as well as fish containing
omega 3 fatty acids. Reducing dietary sodium to no more than 2.4 grams (1 teaspoon) of sodium
a day and adhering to the DASH diet has been shown to reduce systolic blood pressure (Sacks et
al., 2001; Vollmer, Stevens, Svetkey, Lien, & Champagne, 2008).
Several organizations recommend at least 30 minutes of regular aerobic physical activity
most days of the week (USDHHS, 2004; The American Diabetes Association, 2012; &
American Heart Association, 2012). Physical activity reduces systolic blood pressure by 4-9
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mmHg (USDHHS, 2004). Physical activity can include walking, aerobic exercise, swimming,
dancing, using stairs, and flexibility exercises. Losing weight may require more than 30 minutes
a day. Benefits of physical activity reach further than reduction in BP; it reduces stress,
strengthens the heart and lowers risk for pre-diabetes, heart disease and stroke. Increasing the
awareness of the long-term benefits of lifestyle changes can have a positive long lasting effect on
BP without the use of drugs.
Table 2
Lifestyle Modifications to Manage Hypertension
Modification

Recommendation

Approximate Systolic Blood
Pressure Reduction (Range)

Weight reduction

Maintain normal body weight
(body mass index 18.5–24.9 kg/m2)

5–20 mmHg/10 kg weight loss

Adopt DASH
eating plan

Consume a diet rich in fruits, vegetables,
and low fat dairy products with a reduced
content of saturated and total fat.

8–14 mmHg

Dietary sodium
reduction

Reduce dietary sodium intake to no more
than 100 mmol per day
(2.4 g sodium or 6 g sodium chloride).

2-8 mmHg

Physical activity

Engage in regular aerobic physical
activity such as brisk walking
(at least 30 min per day, most
days of the week).

4–9 mmHg

Moderation of
alcohol
consumption

Limit consumption to no more than 2
drinks (1 oz or 30 mL ethanol; e.g., 24 oz
beer, 10 oz wine, or 3 oz 80-proof
whiskey) per day in most men and to no
more than 1 drink per day in women and
lighter weight persons.

2–4 mmHg

Source: (USDHHS, 2004, p. 26)
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Pharmacotherapeutics
It is common practice to implement lifestyle modifications before prescribing drug
therapy (Pettman, Buckley, Misan, Coates & Howe, 2009). Treating preHTN and HTN with
pharmacotherapeutic therapy usually occurs if LMs have failed. The goal for individuals with
preHTN, without any co-morbidity is to reduce BP to normal levels, and to 139/89 mmHg or less
for individuals with HTN. JNC7 (USDHHS, 2004) states that greater emphasis should be placed
on managing systolic hypertension because of increased cardiovascular and renal disease, and
stroke, as the population gets older. Drug therapy therefore would consist of one of the several
different classes of drugs such as diuretics, angiotensin converting enzyme inhibitors,
angiotensin receptor blockers, beta blockers, and calcium channel blockers. Two or more of
these antihypertensive may be required to control blood pressure.
Hypertension Treatment Outcomes
Studies cited in the JNC7 (USDHHS, 2004) document that LM treatment produces a
decrease in BP. Implementing the LM of weight reduction yields a 5-20 mmHg/10kg of weight
loss. An individual usually achieves weight loss through physical activity and that produces an
additional 4-9 mmHg decrease in BP. Replacing unhealthy foods with fruits and vegetables
brings us to the second biggest reduction with the adaption of the DASH diet that yields an 8-14
mmHg decrease in BP. Dietary sodium restriction and moderate alcohol intake reduces BP by
approximately 2-8 mmHg. Studies report that implementing more than one LM has a greater
impact on lowering BP. In 2005 Aldana et al. conducted a study that assessed the impact of
healthful eating and physical activity after attending a 40-hour educational course. BP improved
within only six weeks. Consistent with the JNC7 (USDHHS, 2004), a combination of two or
more lifestyle changes can produce better results.
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Studies published after the JNC7 (USDHHS, 2004) continue to substantiate the impact of
LMs on BP. Elmer et al. (2006) concluded that the established recommendations known as LM,
plus the DASH diet, does lower BP. In 2008 Fleming and Godwin studied the effect of physical
activity and healthy eating on BP and reported a positive result. Svetkey et al. (2009) conducted
a study using physicians as control and intervention group as well as the patients in a control and
intervention group. For the physicians, the interventions were online training modules,
evaluation and treatment algorithm, and quality improvement procedure that assessed clinical
performance measures. The interventions for the patients included 20 weekly group sessions. In
this study the outcome was greatly improved with the combination physician intervention
combined with patient intervention demonstrating a 9.7 ± 12.7 mmHg decrease in BP.
Clinical Problem
Individuals may be unaware that they have preHTN due to the reclassification of
previously identified “normal” systolic and diastolic blood pressure levels. Consequently, they
may not realize their risk for developing HTN and the associated risk for poor health outcomes.
Several patients attending a primary care clinic in rural North Florida have been observed to
have preHTN. A subsequent record review found that some patients also have additional risk
factors such as hyperlipidemia, high blood glucose, and/or are overweight.
Demographic characteristics such as age, minority status, income, education, and rural
residence may be factors that create barriers to HTN prevention (USDHHS, 2004) Access to
exercise programs in school, availability of healthy food choices in school, places of work and
restaurants, coupled with the higher cost of healthy food products is a major barrier. Individuals
have to overcome barriers such as insufficient exercise facilities and access to food stores. It is
difficult for individuals to change lifetime habits. Everyday traditions identified to a particular
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culture, such as high salt diets in the African American and other minority population can be
considered known barriers to adherence (USDHHS, 2004). Patients living in a rural area that are
low income, under or non-insured, unemployed, and have limited access to transportation may be
particularly challenged to adhere to lifestyle modifications.
According to the evidence, making patients aware of their preHTN and guiding them
toward making lifestyle modifications should produce a positive result in lowering their BP as
well as decreasing other CVD risk factors (Johnson et al., 2011). It is essential that Primary Care
Providers (PCP’s) discuss preHTN with patients and counsel them on lifestyle modifications.
Primary Care Providers are well suited to educating patients. Finding ways to motivate an
individual can be done if there is a relationship of trust and respect, which is developed and or
built during patient visits. Good customer service, access to the provider and decreased waiting
time, often leads to patient adherence and the desire to engage in their own care (USDHHS,
2004).
Whittemore et al. (2010) reported a mixed-method clinical trial implementing a lifestyle
program to prevent type II diabetes implemented by nurse practitioners (NPs) in their primary
care facilities. The NPs first completed a questionnaire on confidence of preparedness and
effectiveness in providing LM education and received a two-hour training session on the
Diabetes Prevention Program protocol for enhanced standard care sessions and documentation.
The program provided an adult population at risk for type II diabetes with education, behavioral
and psychological strategies to promote lifestyle change. The enhanced standard care NP group
received 1.5 hours of professional support while the lifestyle change NP group received 4.1
hours of professional support. At the end of the study a survey was sent to participants and a subsample were interviewed to evaluate their satisfaction with the program. Participants reported
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knowing the NP, wanting more information on healthy eating, concern about risk of type II
diabetes, and not wanting to take medicine, as motivating factors for change.
Project Purpose
The purpose of this quality improvement project was to evaluate outcomes of an
educational lifestyle modification program delivered to adults with preHTN in a primary care
rural setting. The study question was: Among adults with preHTN, does an educational lifestyle
modification program implemented in a primary care setting lower blood pressure?
Definition of Terms
Prehypertension
Blood pressure ranging from 120-139 mmHg systolic and/or 80-89 mmHg diastolic
(USDHHS 2004, 7, p. xiv.).
Hypertension
The condition in which a person displays a systolic blood pressure of 140 mmHg or
higher and/or a diastolic blood pressure of 90 mmHg or higher, or is current user of
antihypertensive medication (Rigsby, 2011, p.1).
Lifestyle Modification
Includes weight loss, physical activity, lowering dietary salt intake, smoking cessation,
reducing stress and lowering alcohol consumption (Ebrahim & Smith, 1998, p. 1).
Blood Pressure
That force in arterial structures created by interplay of flow, volume, and constriction
(Buttarro, et al., 2008, p. 572).
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Summary
PreHTN is an important medical issue. Untreated, it can progress to hypertension, which
increases risk for morbidity and mortality associated with CVD. The JNC7 (USDHHS, 2004)
offers treatment approaches including LM and pharmacological therapy. LM interventions such
as weight loss, DASH diet, physical activity, dietary sodium reduction and reduction in alcohol
consumption have been shown to lower BP. Individuals with preHTN may not recognize the
seriousness of this condition and may not be actively engaging in LM that could prevent the
development of HTN. The classification of preHTN prompts providers and patients to actively
intervene and prevent the progression to HTN. The purpose of this project is to assist adult
patients in a primary care setting to lower their BP through LM.
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Chapter Two: Review of Literature
This chapter will describe the search process, assess the JNC7 (USDHHS, 2004), and
discuss the results of the review of literature. A critical appraisal of the JNC7 (USDHHS, 2004)
was conducted using the Appraisal of Guidelines for Research and Evaluation II (AGREE)
instrument (Brouwers et al., 2010). Systematic reviews, meta-analyses, and randomized
controlled trials (RCTs) focused on effect of lifestyle modification on blood pressure in adults
with prehypertension were appraised.
Search Process
A literature search was conducted using The Cochrane Library, EBSCO Host, CINAHL,
Science Direct, ProQuest, and Medline databases. Keywords employed in the search were:
hypertension or prehypertension or blood pressure; and lifestyle modification or behavioral
modification; and African American, diet, physical activity, weight loss, systematic review,
meta-analysis, and RCTs. The search focused on studies published since the JNC7 (USDHHS,
2004) that included publication dates between 1998 and 2012. Inclusion criteria were: diagnosis
of hypertension or preHTN, adults aged 18 years of age or older, with lifestyle modification
treatment. The search revealed 21 research studies of which 13 did not meet inclusion criteria,
for example, studies of treatment with pharmacologic agents. Eight studies met the inclusion
criteria and were used in the analysis (Table 3). The strength of the research evidence was
assessed as well as applicability of methods for primary care practice.
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Clinical Practice Guideline Evaluation
The Seventh Report of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure, JNC7 (USDHHS, 2004), submitted
November 2004 to the journal Hypertension is the clinical practice guideline that drives practice
on hypertension. The JNC7 (USDHHS, 2004) was evaluated using the AGREE II (Brouwers et
al., 2010) instrument to evaluate the quality and applicability of a guideline. It uses the basis of
six domains separated into 23 questions to accomplish an evaluation. The six domains consist of:
scope and purpose, stakeholder involvement, rigor of development, clarity of presentation,
applicability, and editorial independence.
Scope and Purpose
The rationale and purpose for this guideline is explicitly described in the abstract and
then again in the introduction. Their purpose was to increase the awareness, prevention,
treatment, and control of hypertension. In the forward they state that the guidelines are a
synthesis of scientific evidence and guidance geared to busy PCPs. Many key messages can also
be found in the abstract. Identified in this guideline are people with HTN and preHTN. It
identifies treatment with LM, and pharmacotherapy (USDHHS, 2004).
Stakeholder Involvement
The guideline development group dedicated to the management of, and the prevention of
morbidity and mortality, and the consequences of uncontrolled hypertension include a
conglomerate of organizations from all relevant groups. The views of the target population were
sought and the target users are clearly defined. The National Heart, Lung, and Blood Institute
have administered the National High Blood Pressure Education Coordinating Committee,
consisting of 39 major professional, public, and voluntary organizations that participated. The
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federal agencies that also participated were: Agency for Health Care Research and Quality,
Centers for Medicare & Medicaid Services, Department of Veterans Affairs, Health Resources
and Services Administration, National Center for Health Statistics, National Heart, Lung, and
Blood Institute, and the National Institute of Diabetes and Digestive and Kidney Diseases
(USDHHS, 2004).
Rigor of Development
The need to update the guideline was based on the overwhelming publications of new
hypertension observational studies and clinical trials; the need for new, clear and concise
guidelines useful to clinicians; the simplification of BP classification; and the need to get
enhanced public benefit results. Using peer-reviewed, scientific literature that spanned from
January 1997 through April 2003 they developed two versions. The succinct version was
launched in May 2003. The more in depth version also offered justification for the committee’s
recommendation. The committee continued their efforts to stay abreast of the studies being
conducted on hypertension by investigating on four different levels that cover science; longrange planning; professional, patient, and public education; and program organization, thus being
clear and concise in their methods.
The guideline outlined the health benefits and the possible consequence for nonadherence. The committee considered evidence that showed pertinent outcomes of concern to
patients that was of such magnitude it warranted changes in practice. The studies show an
unambiguous link between heart disease, stroke, and renal disease to hypertension. Thirty-three
national hypertension leaders externally reviewed the JNC7 Express and the complete JNC7
(USDHHS, 2004).
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Clarity of Presentation
The key recommendations from this guideline are descriptive in that it is appropriate for
the population and situation in which it addresses. It gives a precise definition of prehypertension
and hypertension and the two stages. The guideline clearly outlines the different classes of
antihypertensive therapy, combinations, and that it may take two or more to meet goal. They also
outline the different classes that work better with other co-morbidities such as diabetes and heart
failure. They include that a combination of LMs such as diet, exercise, weight loss, and physical
activity enhance the positive affect on BP.
Applicability
The JNC7 (USDHHS, 2004) lists facilitators that assist with the reinforcement of LM and
BP control. Those facilitators include but are not limited to nurse managers, pharmacists,
managed care organizations, licensed nutritionists, optometrists and worksite occupational health
departments. Incorporating a LM and BP regimen should be individualized to the patient and
include the patient in the decision making process. Recommendations indicate how the
guidelines can be applied in practice.
The barriers to guideline application were also identified and solutions to those barriers
were described. The primary reason for non-adherence to treatment guidelines related to
medication costs. The patient and primary care provider must agree upon a BP goal, time frame
of achievement and monitoring frequency. The guideline acknowledges that social services or
someone to assist individuals with special needs programs and other resources can help with
adherence (USDHHS, 2004).
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Editorial Independence
This guideline provides the parameters for the different levels and stages of hypertension
including the new category of prehypertension. The recommended approach the guideline
suggests is appropriate for use in the primary care clinical setting. The National Heart Lung and
Blood Institute Health Information Center serves the health professional, and the
recommendations are applicable to patients, and the public as well on things such as prevention,
diagnosis, and treatment.
The JNC7 (USDHHS, 2004) has a perfect score in all domains using the AGREE II tool.
The objectivity of the guideline were clearly written and met, and the overwhelming strength of
the guideline has clearly been justified. The work was supported entirely by the National Heart
Lung and Blood Institute. The Executive Committee and team of reviewers, and writers assisted
as volunteers without remuneration.
Literature Review
Systematic Reviews
The two systematic reviews conducted by Ebrahim & Smith (1998); and Fleming &
Godwin (2008) reviewed a total of 40 RCTs. Ebrahim & Smith (1998) presented studies of 33
RCTs that looked at the effects on systolic BP from different aspects of lifestyle modifications.
Thirty-two studies included LM’s of weight reduction, salt restriction, stress management and
exercise. One study included alcohol reduction. All studies were of six months duration or longer
and reported a reduction of systolic BP in all areas studied with the greatest affect of -5.2 mmHg
with a 95% CI (-8.3, -2.0) from weight reduction. Ebrahim & Smith (1998) determined that
although weight reduction and salt restriction seem to have the greatest effect on systolic BP, a
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larger study is needed, and methodological constraints make it difficult to test LM’s compared to
pharmacological interventions.
Fleming & Godwin (2008), compared studies in primary care, by PCP’s with a control
group using usual care. They measured cardiovascular risk scores, blood pressure, lipid levels,
weight or body mass index (BMI), and morbidity and mortality as outcomes. Three of the six
studies that used BP as an outcome found that there was small but significant benefit to LM
intervention. Of the seven RCTs compared, four found significant positive effect on the
outcomes of interest and two found consistent effects across the several outcomes. Although
statistically significant, and showing that the main effects were on blood pressure and lipid
levels, they were rather small. The authors concluded that PCP’s time might best be spent
counseling patients at highest risk of disease given the small improvement in BP among lower
risk groups.
Meta-Analyses
Two meta-analyses reviewed 51 articles, all of which studied BP and BMI. Some articles
reviewed waist circumference, dyslipidemia, fasting plasma glucose, and smoking and drinking
as well. One study by Guo et al. (2011) was conducted after the guideline was released. Between
all studies a total of 255,615 participants were included. Both analyses conclude that LM has a
positive effect on decreasing blood pressure.
Neter, Stam, Kok, Grobbee, & Geleijnse (2003) conducted a meta-analysis reviewing
studies published on the influence of weight reduction on blood pressure. This meta-analysis
documents the improvement in BP by the reduction in weight gain in hypertensive patients,
especially those taking antihypertensive medications. They identified 25 articles that met their
criteria, especially non-pharmacological weight reduction. Energy or calorie restriction,
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increased physical activity and sometimes a combination of both were used in the meta-analysis
of the RCTs. Whelton, Chin, Xin & He (2002), concluded that BP was considerably reduced
with minimal overall weight loss, implying that exercise alone lowers BP freely of changes in
body weight.
In 2011, Guo et al. (2011) reviewed 26 studies of which 20 were cross-sectional and six
were longitudinal studies with a combined sample size of 250,741 individuals. Their outcome
measures were the predictors of preHTN; BMI, and waist circumferences, dyslipidemia, fasting
plasma glucose, smoking and drinking, and predictors of progression from preHTN to HTN
(increased age, male sex, low education status and C-reactive protein).
Guo et al. (2011) also found significant association of fasting plasma glucose, total
cholesterol, and LDL-C with HTN. Eight studies done on fasting plasma glucose were included
in this meta-analysis. With 10 studies investigating the correlation between smoking and
drinking eight of which reported drinking met with conflicting results. Although they report their
limitations as only searching PubMed and The Cochrane Library and admit there needs to be
further study, both meta-analyses conclude by saying many of the risk factors mentioned
preclude the progression of preHTN to HTN.
Randomized Control Trials
Four randomized control trials reported on outcomes of blood pressure from any form of
lifestyle modifications. A total of 2,133 individuals participated in these trials. One study by
Aldana et al. (2005) also measured knowledge, nutrition, physical activity and other chronic
disease risk factors. Overall the studies compared usual care or no intervention to at least one
lifestyle modification. Three of the four studies held an educational intervention course of some
kind. One study however assigned the control group a typical United States diet and the DASH
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diet was assigned to the intervention group (Sacks et al., 2001). Another study included the
physicians as part of the study and used internet-based training, self-monitoring and quarterly
feedback reports as the intervention (Svetkey et al., 2009). The latter two studies both showed
significant positive effect of the interventions used.
Elmer et al. (2006) is continuation of a prior study at 18 months, however their measured
outcomes were the individual components of lifestyle modification. They used weight,
cardiorespiratory fitness, and physical activity assessed at baseline, six months, and 18 months.
The results after 18 months showed an increase in fitness measured by heart rate for all groups.
After 18 months, all three groups showed a decrease in absolute blood pressure. Their
conclusion, individuals with preHTN and stage 1 HTN can implement LM and sustain them for
an extended period, control their BP, and reduce their risk for CVD.
After Aldana et al. (2005) conducted the last RCT reviewed, their conclusion support the
RCTs presented earlier. They used the Coronary Health Improvement Project intervention to
which is focused on participants’ improvement in cognitive understanding of the importance of a
healthy lifestyle, improvement in nutrition and physical activity, and improvements in variables
that affect diabetes, HTN, CVD and cancer. They held a 40-hour educational course delivered
over a four-week period, meeting four times a week for two hours. The reported dramatic change
in BP among the participants in the intervention group was that prevalence of HTN decreased
from 18.5 % to 7.5% at follow up, supporting lifestyle modification.
Strength of the Evidence
The purpose of the literature review was to appraise the evidence of the effectiveness of
an educational intervention of LM changes on BP in adults with preHTN. There is a broad scope
of evidence that has been steadily and methodically reviewed. The systematic reviews are
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considered the most rigorous and the strongest level (Level 1) of evidence and approach to
minimization of bias in summarizing research (Melynk & Fineout-Overholt, 2011). The five
randomized control trials reviewed are considered to be Level II evidence. They are generated
from at least one well-designed randomized clinical trial (Melynk & Fineout-Overholt, 2011).
Conclusion
This literature review supports that lifestyle modification has a positive effect on
lowering blood pressure in adults. This suggests that educational intervention creates awareness
of the many risk factors leading to CVD and that those risk factors can be changed. As shown in
the study done by Svetkey et al. (2009), primary care providers can also benefit from educational
intervention. It seems to be the consensus of most of the studies reviewed that some participants
fail to continue with behavioral changes once the study is completed. It would be ideal to see
individuals adopt healthy lifestyle behaviors and maintain them for life. Based on the findings in
this literature review, LM’s should be implemented. Evidence shows that this implementation
can reduce BP, thereby preventing the progression from preHTN to hypertension. The
interventions in these studies, some being complex, are applicable to practice. In the primary
care setting these very same standards of care can be implemented for the type of population that
is unique to a rural area.
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Table 3
Literature Analysis of Lifestyle Modifications Effect on Blood Pressure
Author
(Date)
Ebrahim &
Smith
(1998)

Design

Sample

Outcome
Measures
BP

Intervention

Results

Limitations

Level I
Systematic
Review

25 articlesfrom 19661995

Salt restriction,
weight reduction,
stress management,
exercise, & alcohol
reduction

Control group: 95% CI: salt restriction -2.9 (5.8,0.0); weight loss -5.2(-8.3,-2.0); stress control
-1.0(-2.3,+0.3); & exercise -0.2(-2.8,+2.4).
Normotensive: salt restriction -1.3(-2.7,+0.1);
weight loss -2.8(-3.9,-1.8); exercise -0.2(2.8,+2.4), & alcohol reduction -2.1(-4.1,-0.1).
Weak evidence except for weight loss.

Some low
methodological
quality and not
well controlled.
Findings may be
overestimates of
effect.

Fleming &
Goodwin
(2008)

Level I
Systematic
Review

7 RCTs

BP, lipids,
BMI,
cardiovascular
risk scores,

Physical activity,
healthy-eating

2 studies showed positive results in BP (2 mm
Hg), as compared to control group with size of
effects small.

Meta-analysis not
possible due to
non-homogeneity
of study
populations.

Guo et al.
(2011)

Level I
MetaAnalysis

26 articles; 20
crosssectional; 6
longitudinal.
Sample of
250,741
individuals

BMI and waist
circumference,
dyslipidemia,
Fasting Plasma
Glucose,
smoking and
drinking

None. Assessing
epidemiology of
preHTN.

Overall pooled prevalence-36%; males>females
at (40% vs 33%). Standardized mean difference
for BMI was 1.37(95% [CI], 1.20-1.55); total
cholesterol, 8.08(95% CI, 6.71-9.46) for LDL
5.14(95% CI, 3.09-7.18); and for FPG, 4.23 (95%
CI, 3.28-5.18) all showed more significant in
females. Pooled OR was 1.13 (95% CI, 0.931.37) for smoking; 0.98 (95% CI, 0.69-1.39) for
drinking. Findings identify modifiable risk factors
amendable to intervention.

Search databases
limited to PubMed,
Cochrane, English
and Chinese.
Potential for
measurement error
of outcomes.
Time delay
between search and
publication.

Neter et al.
(2003)

Level I
MetaAnalysis

25 RCTs;
4874
participants

BP, BMI

N/A

Net weight reduction of -5.1kg (95% CI, -4.88—
2.25) by energy restriction, increased physical
activity or both reduced SBP by -4.44 mmHg
(95% CI, -5.93—2.95); DBP -3.57 mmHg (95%
CI, -4.88—2.25); Significantly lower BP
reductions with avg weight loss >5 kg (-6.63
mmHg [95% CI, -8.43—4.82] vs -2.70 mmHg
[95% CI, -4.59—0.81]) and DBP (-5.12 mmHg

Not specified.
RCT’s used in
analyses were
noted to have high
internal validity.
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Author
(Date)

Design

Sample

Outcome
Measures

Intervention

Results

Limitations

[95% CI, -6.48—3.75] vs -2.01 mmHg [95% CI,
-3.47—0.54]). Strong evidence for weight loss.
Aldana et
al.
(2005)

Level II
RCT

337
volunteers.
Age 43-81.

Change in
health
knowledge,
nutrition,
physical
activity, risk
factors
including BP

40-hour
educational course
over 4 weeks, 4
times per week for
2 hours..

Beneficial mean changes in scores tended to be
significant for the intervention group. Variables
improved scores: health knowledge, % body fat,
total steps/week and most nutrition variables.
Improvement in resting heart rate, total
cholesterol, LDL cholesterol, and SBP and DBP.
Control group-small but significant
improvements in health knowledge, SBP and
DBP, glucose, and some nutrition variables.

Participants highly
motivated and had
higher ed level
compared to
community.
Short intervention
(4 wks) with short
follow (6 mos)

Elmer et al.
(2006)

Level II
RCT
PREMIER
18 month
results

810 adults
with preHTN
or stage 1
HTN

BP

1.Behavioral
intervention,
2.Behavioral plus
Dash diet
3.Advise only

Blood pressure decreased in all three groups.
Reduction was greater for participants in groups 1
and 2 but not significantly different compared to
the advice only group. Participants were able to
sustain lifestyle changes over time.

Sacks et al.
(2001)

Level II
RCT,
Multi-site

412 adults
with BP
>120/80

BP

30 day salt
reduction + DASH
diet

DASH diet with low sodium level reduced BP by
7.1 mmHg (p<0.001) in participants without
HTN; by 11.5 mmHg (P=0.03) in participants
with HTN. Combination had greater effect.

Svetkey et
al.
(2009)

Level II
RCT

8 primary
care
practices;
32 MD’s, 574
patients

Change in SBP
at 6 months.
Change in
DBP at 6 & 18
months.
Height,
weight, intake,
physical
activity,
medications,
lab measures.

1. Trained MD 18
mos. Intervention.
2. Control MD,
usual care.
3.Patient 20 week
LM group session
4. Patient control
usual care advice
for BP control
office visit.

MD control + Patient control, blood pressure fell
by mean 6.7 ± 12.8 mmHg at 6 mos;
MD intervention + Patient control, blood pressure
fell by 5.3 ± 12.1 mmHg
Pt intervention + MD control, blood pressure fell
by 7.1 ± 12.1 mmHg.
MD intervention + Patient intervention, blood
pressure fell by 9.7 ± 12.7 mmHg significant
compared to other groups, p=.0072
At 6 months there was a significant interaction
effect for MD + Patient intervention.

Multi-site
comprehensive
RCT with
population
heterogeneity.
Volunteers
randomized.
Multi-site trial with
population
heterogeneity.
Volunteer
randomized.
Patient completion
at 6 months was
91% and at 18
months was 88%.
Only 10% of
patients were
randomized
therefore not
generalizable.
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Chapter Three: Methods
This chapter describes design, source, sample, collection, measures and analysis of the
data. The design is a retrospective review of existing data obtained from patient records pre and
post education about lifestyle modification. The answer to the project question, “In adults with
prehypertension does education on lifestyle modification affect blood pressure,” was explored.
Procedure, Sample, and Data Collection
An educational intervention on lifestyle modification for adults with preHTN was
implemented in a rural primary care practice following recommendations of the JNC7
(USDHHS, 2004) and approval of the Primary Care Physician of the clinic. The educational
lifestyle modification program was delivered by the Nurse Practitioner to adult patients 18 years
of age and older who were identified as being prehypertensive during a non-related scheduled
office visit beginning in February 2013. For intervention details and script See Appendix A.
Appendix B includes a color brochure designed and distributed by the NP regarding blood
pressure and lifestyle modification. A web link to a 1.32-minute educational video was also
shown during the visit. The LM intervention included counseling related to physical activity,
weight loss, diet, sodium intake, alcohol intake, and smoking cessation.
Data collected during the visit per customary clinical practice was BP, height, weight,
and BMI, and was recorded in the patient electronic health record (EHR). Patients identified as
prehypertensive were scheduled for free monthly blood pressure checks in the primary care
office. A medical assistance trained in BP measurement protocols conducted the blood pressure
follow-up checks. The medical assistant also received 30 minutes of training on how to maintain
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a separate paper log of patients referred for blood pressure. Following standard practice the
medical assistant recorded blood pressure, height and weight, and BMI into the electronic health
record (EHR). Once the quality improvement project was completed the medical assistant was
instructed on how to extract that information from the EHR, assign a code to the individuals in
order to de-identify the data and enter it into an Excel spreadsheet. Once verified and analyzed,
the medical assistant used the office shredder to destroy all project-related documents.
Measures
Descriptive Variables
Descriptive variables extracted from the EHR on patients who were prehypertensive
included age in years, gender, as well as clinical measures of BP, height, weight, and BMI. Age
and gender were used to describe the population sample. Coding of these variables is described
in Table 4.
Outcome Variables
Blood pressure was the outcome of interest. Actual blood pressure readings were
extracted from the EHR. The first BP measurement was the baseline and used to compare and
categorize subsequent measures. A categorical variable indicating decrease in BP was generated
and coded as yes decrease, no decrease, or no change in BP for subsequent measures.
Participants who did not return for monitoring were coded as “lost to follow-up” in blood
pressure.

24
Table 4
Variables Used for Project and Their Coding
Descriptive Variables
Age in years

Coding
18-99

Gender

1=male, 2=female

Weight in pounds

00.0-000.0

Decrease in weight

No=0, Yes=1, No need=2

Height in inches

00

Body Mass Index (BMI)

00.0

BMI category

1=Underweight = Below 18.5
2=Normal = 18.5-24.9
3=Overweight = 25.0-29.9
4=Obese = 30.0 and above

Improved BMI

No=0, Yes=1, No need=2

Outcome Variable
Blood pressure measured in 000 systolic
mmHG
00-000 diastolic
Decrease in blood pressure

No=0, Yes=1, Lost to follow-up=2

Data Analysis
Data was obtained from the EHR and entered into an excel file by the medical assistant.
A statistician was consulted. The data was analyzed using SPSS® statistical software (Version
21.0, 2013, Excel, 2010). Categorical variables were described using counts and percentages.
Continuous variables were described using median, means, standard deviations (SD), and ranges
(minimum, maximum). The change in systolic and diastolic blood pressure from baseline to end

25
of study was explored using descriptive analysis. Bar charts were used to show relationships
between variables.
Feasibility
The project was feasible and additional resources were not required. The regular office
visit was used to implement the project using customarily collected data. The educational
lifestyle modification program was part of the regular office visit taking less than 20 minutes of
time. The use of available office supplies such as copy paper and copy machine was used to
make copies of BP Fact Sheet and DASH diet plan.
Protection of Human Subjects
This quality improvement project commenced upon approval from the Institutional
Review Board (IRB) of the University of North Florida (UNF) and Baptist Medical Center (see
Appendix C and D). The UNF IRB deemed the project “not research involving human subjects”
and therefore not necessary to be reviewed or approved by the UNF IRB. Baptist Medical Center
IRB reviewed and approved the project via expedited review process. A retrospective chart
review was conducted to extract de-identified patient descriptive and outcome variables among
patient’s categorized as prehypertensive by an employee in the primary care practice. The risk to
patients was considered to be minimal and individual patient informed consent was not required.
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Chapter Four: Results
This chapter reports results that answer the quality improvement project question: Does
an educational lifestyle modification program implemented in a primary care setting lower blood
pressure among adults with preHTN? Data was collected from established patients in the primary
care setting between February 1, 2013 and June 30, 2013. Results describe the sample, the
intervention, and report the project outcomes.
Project Sample
The quality improvement project was conducted at a rural primary care clinic affiliated
with a large network of clinics and hospital network. There were five participants in total. The
participants mean age was 36.4 years (SD=6.9 years), with a range from 26 years to 43 years.
Three (60%) of the five patients were female. The patients had a mean height of 67.6 inches
(SD=3.4 inches), with a range from 64 inches to 72 inches. At the beginning of the study the
mean weight was 204.6 pounds (SD=56.6 pounds), with a range from 158 pounds to 299 pounds.
Their BMI decreased from baseline to end of study on average by .87 (SD=1.0), with a range
from -1 (increase) to 2 (decrease). With respect to their heart rate the mean rate was 81
(SD=12.7), with a range from a heart rate of 63 to 96 beats per minute. The demographic
information related to the patients is listed in Table 5. In this case, each baseline reading is
matched with the reading at 3 months (end of study). For each patient, the difference between
baseline and 3 months was calculated using descriptive analysis to determine change in blood
pressure readings pre and post program.
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Intervention and Follow-Up
On initial visit all identified prehypertensive adult patients were counseled by the PI
about LMs, they viewed an educational video that gave a basic description of hypertension, and
received a PI developed brochure. During the interactive time with the patient, the PI discussed
lifestyle modification interventions such as weight loss, DASH diet, physical activity, dietary
sodium reduction and reduction in alcohol consumption with each patient. All patients were
instructed to return for monthly follow-up visits for 3 months. Each visit included BP, height and
weight, heart rate and BMI checks.
Table 5
Description of Patient Characteristics
N
Age
BMI change from
Baseline to End
BMI Baseline
BMI End of study
Heart rate change from
Baseline to End of study
Heart Rate Baseline
Heart Rate End of study
Weight change from
Baseline to End of study
Weight Baseline
Weight End of study
Height (Inches)
Valid N

Minimum Maximum

Mean

Std.
Deviation
36.40
6.914
.87
.951

Median

5
5

26
-1

43
2

39.00
1.10

5
5
5

26.30
27.00
-3

40.50
39.15
20

31.0600
30.1900
5.00

5.55050
5.11669
9.434

29.90
28.10
2.00

5
5
5

63
66
-3

96
88
10

81.00
76.00
3.80

12.728
8.124
4.764

86.00
76.00
5.00

5
5
5
5

158
161
64

299
297
72

204.60
200.80
67.60

56.602
57.081
3.362

178.00
173.00
67.00
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Outcomes
The study began with SBP baseline median of 129 mmHg, with a range from 126 mmHg
to 137 mmHg. The DBP baseline had a median of 86 mmHg, and a range of 82 mmHg to 90
mmHg. At the end of the study all five patients had a decrease in SBP and DBP, respectively.
After participants incorporated one or more LMs, the median SBP decreased to 121 mmHg, and
ranged from 108 mmHg to 128 mmHg. The end of study median DBP was decreased to 78
mmHg, and ranged from 77 mmHg to 83 mmHg. The outcome BP from baseline to end of study
for SBP and DBP is presented in Table 6 and Figure 1. Patients who engaged in LMs had a
clinically significant decrease in BP.
Table 6
Outcome Blood Pressure
N
SBP change from Baseline to
End
DPB change from Baseline to
End
SBP Baseline
DBP Baseline
SBP End of study
DBP End of study
Valid N

Minimum Maximum

Mean

Std.
Deviation
9.80
5.450

Median

5

3

18

9

5

3

9

6.40

2.408

7

5
5
5
5
5

126
82
108
77

137
90
128
83

130.00
85.40
120.20
79.00

4.183
3.130
7.662
2.550

129
86
121
78
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Figure1. Blood pressure: Systolic Pressure and Diastolic Pressure
Summary
The results of this quality improvement project indicate that implementing lifestyle
modification and blood pressure monitoring in primary care is feasible. All patients received a
minimum of one LM education intervention through initial contact. Findings indicate that blood
pressure among this small sample was lowered at the end of the three month monitoring period.
Statistical significance cannot be inferred due to small sample size; however, lower blood
pressure would be significant for the individuals.
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Chapter Five: Discussion
This chapter provides a discussion of the major findings of this quality improvement
lifestyle modification project. The following will be discussed: the major findings and a
comparison to the findings of similar studies, the clinical relevance to nursing practice, the
study’s limitations, and suggestions for future research.
Major Findings
An educational lifestyle modification program implemented in a primary care setting can
lower blood pressure among adults with preHTN. The results are consistent with first line
therapy found in current clinical practice guidelines for adults with prehypertension (USDHHS,
2004). Lifestyle modification is an important part of treating preHTN and preventing progression
to HTN. This finding is consistent with the two systematic reviews findings of Ebrahim and
Smith (1998) and Fleming and Godwin (2008). Incorporating one or more interventions of
lifestyle modification can reduce adult prehypertension. In the Svetkey et al. (2009) study, the
physicians received training on JNC7 (USDHHS, 2004) guidelines, LM for BP control,
treatment algorithms, a decision tree on a pocket sized card, and quarterly feedback reports. The
patient intervention consisted of 20 weekly group sessions over six months on LMs. The
combination of physician and patient intervention yielded a total decrease of 9.7 mmHg ± 12.7
mmHg in systolic blood pressure.
Clinical Relevance
As a chronic disease, hypertension is one of the most prevalent conditions in the United
States. It is responsible for $76.6 billion in health care costs, medications, missed days from
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work not to mention a risk factor for stroke, heart and kidney disease (Johnson et al., 2011).
There were many risk factors for preHTN observed in some patients including weight, high
cholesterol, diabetes and other diseases. The justification for concern of cardiovascular disease is
more likely to influence clinical practice. To implement this practice change into the clinical
setting is not only feasible for all providers to accomplish but recommended. Lowering one’s
blood pressure can also reduce cholesterol levels and blood glucose. Aldana et al. (2005) states
improvements in nutrition and physical activity, LMs that also lower BP, improves whole body
glucose tolerance, increases insulin sensitivity, and amount of glucose transporter.
Lifetime risk of HTN increases as the general population ages. This study examined the
effectiveness of incorporating a practice change as delineated by the JNC7 (USDHHS, 2004)
regarding blood pressure. Implementing LMs in the clinical setting can be a challenge. Not all
patients are receptive to changing behaviors. Therefore, the approach and presentation is crucial.
Educating patients of diseases that HTN is associated with (heart –LV hypertrophy, angina, heart
failure; brain – stroke or transient ischemic attack; chronic kidney disease; peripheral arterial
disease; retinopathy), and that modifiable LMs play a vital role in lowering BP, is therapeutic
and follows along with current JNC7 (USDHHS, 2004) guidelines.
Once prehypertenive patients are identified, it takes a few extra minutes to discuss the
progression to HTN, the diseases HTN is associated with, showing the short video, and/or
providing educational materials and answering questions to help guide patients on implementing
the different LMs that can decrease blood pressure. At the end of data collection all participants
had a lower BP reading compared to the baseline BP. The lower BP suggest that the participants
followed some or all of the recommended LM practices such as diet rich in whole grains, fruits
and vegetables, and low-fat diary products (DASH diet) (can reduce BP by 8-14 mmHg), eating
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less sodium (can reduce BP by 2-8 mmHg), limiting alcoholic beverages can reduce BP by 2-4
mmHg), engaging in exercise (can reduce BP by 4-9 mmHg), losing weight (can reduce BP by 520 mmHg/kg), and smoking cessation (can reduce overall risk for cardiovascular disease)
(USDHHS 2004).
The JNC7 (USDHHS, 2004), calls for providers to begin prompt implementation of LMs
for adults with preHTN to stop the progression to HTN. Because of the known effectiveness of
LMs modifications, Guo et al. (2011) suggests providers also be aware of individuals at an
increased risk for cardiovascular disease. Once identified, providers should encourage patients to
incorporate as many LMs to reduce modifiable risk factors for a greater benefit. From a clinical
perspective it is crucial that providers begin this intervention as the standard of care.
As early as two months ago the USDHHS released the Eighth Joint National Committee
(JNC 8) recommending nine new guidelines on the management of adult hypertension. The
greatest change is in patient’s aged ≥60 years to initiate pharmacologic treatment at SBP ≥ 150
mmHg or DBP ≥90 mmHg to a goal of SBP ≤150 mmHg and DBP ≤90 mmHg. The new JNC 8
has not changed the parameters for the new PreHTN classification and LM remains the
recommended treatment so the results of this project are not affected by the update of the
guidelines. Providers should be aware that guidelines change and are revised and updated
periodically as new evidence emerges.
Limitations
This quality improvement project targeted adults with preHTN in a rural setting. The
main limitation to this project was the limited number of patients with prehypertension. In many
cases, patients were either already diagnosed with HTN or were already being treated with
medication therapy. Therefore sample size became the major limitation to this study. Secondly,
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due to administrative security settings on the computers, in the office, a personal electronic
device had to be used to show the short video on basic HTN. Had access to the Internet been
possible on clinic computers, the process would have been shorter and the provider could have
spent more time with the patient on the educational program. Third, even though the clinical
setting allowed participants to schedule follow-up BP readings freely and at their convenience,
there were participants lost to follow up. The main reason stated for this was time off from work.
Many participants were unable or unwilling to take the time off from work during clinic hours.
Offering extended hours for a specific day of the month for return visits could have provided for
a lower loss to follow up rate. Also, individuals may have returned for clinic visits if they
received reminders.
Implication for Future Study
Future study should include identifying strategies to increase patient participation and
improve sample size. This can be achieved by increasing patient awareness of guidelines,
consequences of HTN, and benefits of incorporating one or more lifestyle modifications into
their daily lives. Finally, more study is needed and would be beneficial if long-term benefits of
LMs that reduce disease morbidity and mortality are studied.
Conclusion
This study suggests that an educational lifestyle modification program implemented in a
primary care setting is feasible and can have a positive effect on lowering blood pressure among
adults with preHTN. Providers can confidently promote LMs to reduce BP using JNC7
(USDHHS, 2004) guidelines and available educational materials and resources. Whittmore et al.
(2010) reports that the implementation becomes easier over time. The significance to patients
includes positive health outcomes and reduced reliance on pharmaceutical measures to control
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HTN. Consequently, patients with their providers can impact healthcare costs, prevent the
progression of preHTN to HTN, and reduce stroke, heart, kidney, and other diseases.
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Appendix A
Lifestyle Modification (LM) Intervention
Intervention and First Line Treatment of Prehypertension in Primary Care
During an office visit the primary care provider addresses blood pressure with the patient
using the 5 A’s Behavior Change Model (Assess, Advise, Agree, Assist and Arrange) as a guide.
Ask and Assess about lifestyle behaviors:
NP might say
“Good morning/afternoon, in looking at your vital signs, I notice your blood pressure is slightly
elevated”. “Can we talk about that for a minute?”[Asking permission]
“Did you know that what was once considered normal BP, 120’s/80’s, is now considered
prehypertension by the new JNC 7 guidelines?” “Although your blood pressure is not classified
as high blood pressure, it could progress to it”
“The new guidelines now want providers to intervene at this time to prevent the progression to
hypertension.” This is done with what is called Lifestyle modifications; do you know what those
are?”
[Assessing basic knowledge of HTN and assessing lifestyle]
Information provided includes: Explain prehypertension to patient. Show short 1:32 second
educational video about the basics of HTN. The video is completely on the layperson’s level of
understanding. It demonstrates blood flow, factors affecting it, and the dangers resulting from
HTN.
After the video is shown the NP then uses motivational interviewing techniques to advise the
patient about changing the behaviors that are applicable. Ask permission to talk about LM, this
shows respect and caring for patient.
“What is your daily diet like?” “Do you exercise regularly?”
If they smoke, are overweight, and/or drink alcohol the NP might say:
“I see that you are a daily smoker, how much do you smoke?” “Any thoughts on quitting?”
“What kind of alcohol do you drink and how much?” “Any thoughts on quitting or limiting
intake?”
Advise and Agree to change LM: Motivational interviewing:
NP might say
“Would you be interested in learning how you can reduce your blood pressure?”
“Let’s talk about changing your daily diet and incorporating an exercise regimen?”
“Did you know that cutting your sodium intake down to 2400 grams a day, 1 teaspoon, can
reduce you BP by approximately 2-8 points”, and that brisk walking 30 minutes a day for most
days of the week reduces your BP by 4-9 points?”
Information provided includes: Patients that are interested in reducing BP the NP might say, “I
am glad you recognize the potential benefits of lifestyle changes.” A LM brochure is then handed
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and reviewed with the patient. This leads to in depth counseling on benefits of LM, harms of
HTN, and short and long-term goal setting.
For the prehypertenive patient unsure of using LM to reduce BP the NP might say “what
concerns you most about reducing your BP?” This might introduce barriers and challenges that
need to be addressed and overcome. The patient may not perceive a need to change if they are
not experiencing any apparent problems at this time. Giving this patient brief advice on BP
reduction may lead to future interest in LM changes when those challenges and barriers are
reduced or removed. The NP might say, “Perhaps we can address this again at your next visit.”
Assist and Arrange LM incorporation: The patient who desires to make LM changes and set a
goal date.
Information provided includes: The NP provides counseling based on the JNC7 (USDHHS,
2004) and on individual assessments of patient’s lifestyle. The NP helps the patient devise a SelfManagement Action Plan. The plan addresses barriers and concerns, and strategies that will
encourage and increase the chance of successful LM incorporation. A handout on the Dietary
Approach to Stop Hypertension (DASH) diet is given to assist the patient in knowing the proper
foods to eat. The LM brochure also has links to websites the patient can access at their own
convenience to aid in their knowledge and success of these changes.
Arrange for follow-up:
Information provided includes: At monthly intervals the patient will visit the office for routine
height and weight, and BP measurements. The patient may also call the office or schedule an
appointment with the NP for any questions or concerns.
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Appendix B
Lifestyle Modification (LM) Intervention Brochure
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Appendix C
IRB Approval Documents
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820 Prudential Drive, Suite 413
Jacksonville, Florida 32207
Phone: 904.202.2127
Fax: 904.202.2331
ircsubmission@bmcjax.com

MEMORANDUM

TO:

Andrea M. Patterson, MSN, FNP-BC

Signature
Deleted

FROM:

Michael Joyce, MD, PhD

DATE:

November 11, 2013

RE:

Expedited Review – Initial Approval

The Institutional Review Board (IRB) of Baptist Medical Center (BMC) met on October
17, 2013 and the following new protocol was reviewed and approved via expedited
review for a period of one year:
#13-66, Baptist, "Evaluating The Effects of an Educational Lifestyle
Modification Intervention on Blood Pressure in Adults with Hypertension"
-Introductory Questionnaire; Protocol Submission Checklist; Protocol Version 1
dated 12 July 2013; HIPAA Waiver; UNF IRB Waiver dated 11 October 2013
The anniversary date for this study is October 16, 2014. At that time, please submit a
report of your experiences with this protocol.
Should you have any questions, please contact the IRB office. The BMC IRB meets the
requirements in 21 CFR 56 (Rev.), 45 CFR 46 (Rev.) and ICH (E6) GCP guidelines.
Good luck with this endeavor.
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Signature Deleted
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